Reducing the cost of proton pump inhibitors by adopting best practice

Quality in Primary Care

Volumn 17, Issue 1, 2009, Pages 15-21

  Hughes, Jeffery D ^a   Tanpurekul, Wanitchaya ^a   Keen, Neil C ^b   Ee, Hooi C ^c  

^a CURTIN UNIVERSITY   (Australia)

^b CANBERRA HOSPITAL   (Australia)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Gastro aesophageal reflux; Guidelines; Proton pump inhibitors; Step down therapy

Indexed keywords

AGED; AUSTRALIA; BENCHMARKING; COHORT STUDIES; COST OF ILLNESS; DRUG COSTS; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PROTON PUMP INHIBITORS; QUESTIONNAIRES;

EID: 63049109875     PISSN: 14791072     EISSN: 14791064     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Shi S and Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. European Journal of Clinical Pharmacology 2008;64:935-51.
2. Kahrilas PJ. Gastroesophageal reflux disease. New England Journal of Medicine 2008; 359:1700-7.
3. Robinson M. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors - overview and clinical implications. Alimentary Pharmacology and Therapeutics 2004;20(suppl 6):1-10.
4. de Carle DJ. Gastro-oesophageal reflux disease. Medical Journal of Australia 1998;169:549-54.
5. Waldum HL and Brenna E. Personal review: is profound acid inhibition safe? Alimentary Pharmacology and Therapeutics 2000;14:15-22.
6. Laine L, Ahnen D, McClain C, Solcia E and Walsh JH. Review article: potential gastrointestinal effects of longterm acid suppression with proton pump inhibitors. Alimentary Pharmacology and Therapeutics 2000;14:651-68.
7. Health Insurance Commission of Australia, 2004. www.hic.gov.au (accessed 1 December 2008).
8. Australian Government Department of Health and Ageing. Australian Statistics on Medicines 2006 (12e). www.health.gov.au/internet/ main/publishing.nsf/Content/pbs-pubs-asm2006 (accessed 1 December 2008).
9. Martin RM, Lim AG, Kerry SM and Hilton SR. Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care. Alimentary Pharmacology and Therapeutics 1998;12:797-805.
10. Mat Saad AZ, Collins N, Lobo MM and O'Connor HJ. Proton pump inhibitors: a survey of prescribing in an Irish general hospital. International Journal of Clinical Practice 2005;59:31-4.
11. Parente F, Cucino C, Gallus S et al. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Alimentary Pharmacology and Therapeutics 2003;17:1503-6.
12. McManus P, Marley J, Birkett DJ and Lindner J. Compliance with restrictions on the subsidized use of proton pump inhibitors in Australia. British Journal of Clinical Pharmacology 1998; 46:409-11.
13. Foroughi N, Peterson GM and Galloway JM. Drug utilisation review of orneprazole. Australian Journal of Hospital Pharmacy 1993; 23:394-7.
14. Naunton M, Peterson GM and Bleasel MD. Overuse of proton pump inhibitors. Journal of Clinical Pharmacy and Therapeutics 2000;25:333-40.
15. Pillans PI, Kubler PA, Radford JM and Overland V. Concordance between use of proton pump inhibitors and prescribing guidelines. Medical Journal of Australia 2000;172:16-18.
16. Chow SL, Luzier AB, DiTusa L, Snyder BD and Izzo JL Jr. Acid-suppressive therapy use associated with anti-hypertensive agents. Journal of Clinical Pharmacology 2001;41:750-6.
17. Australia Department of Health and Aged Care. Schedule of Pharmaceutical Benefits for Approved Pharmacists and Medical Practitioners Operative from 1 April 2005. Canberra, ACT: The Dept, 2005.
18. Therapeutic Guidelines Ltd, Victorian Drug Usage Advisory Committee, Writing Group for Therapeutic Guidelines (Gastrointestinal). Therapeutic Guidelines: gastrointestinal (3e). North Melbourne: Therapeutic Guidelines, 2002, p. 192.
19. National Prescribing Service. NPS News 46: Proton pump inhibitors, 2006 www.nps.org.au/_data/assets/pdf_file/0016/23821/news46.pdf (accessed 1 December 2008).
20. Dent J, Jones R, Kahrilas P and Talley NJ. Management of gastro-oesophageal reflux disease in general practice. British Journal of Medicine 2001;322:344-7.